Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Neuromodulation Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Deep Brain Stimulation
  • 1.4.3 Spinal Cord Stimulation
  • 1.4.4 Transcranial Magnetic Stimulation
• 1.5 Market by Application
  • 1.5.1 Global Neuromodulation Market Share by Application (2014-2025)
  • 1.5.2 Depression
  • 1.5.3 Parkinson’s
  • 1.5.4 Tinnitus
  • 1.5.5 Alzheimer’s
  • 1.5.6 Epilepsy
  • 1.5.7 Ischemia
  • 1.5.8 Obesity
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Neuromodulation Market Size
• 2.2 Neuromodulation Growth Trends by Regions
  • 2.2.1 Neuromodulation Market Size by Regions (2014-2025)
  • 2.2.2 Neuromodulation Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Neuromodulation Market Size by Manufacturers
  • 3.1.1 Global Neuromodulation Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Neuromodulation Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Neuromodulation Market Concentration Ratio (CR5 and HHI)
• 3.2 Neuromodulation Key Players Head office and Area Served
• 3.3 Key Players Neuromodulation Product/Solution/Service
• 3.4 Date of Enter into Neuromodulation Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Neuromodulation Market Size by Type (2014-2019)
• 4.2 Global Neuromodulation Market Size by Application (2014-2019)

5 United States

• 5.1 United States Neuromodulation Market Size (2014-2019)
• 5.2 Neuromodulation Key Players in United States
• 5.3 United States Neuromodulation Market Size by Type
• 5.4 United States Neuromodulation Market Size by Application

6 Europe

• 6.1 Europe Neuromodulation Market Size (2014-2019)
• 6.2 Neuromodulation Key Players in Europe
• 6.3 Europe Neuromodulation Market Size by Type
• 6.4 Europe Neuromodulation Market Size by Application

7 China

• 7.1 China Neuromodulation Market Size (2014-2019)
• 7.2 Neuromodulation Key Players in China
• 7.3 China Neuromodulation Market Size by Type
• 7.4 China Neuromodulation Market Size by Application

8 Japan

• 8.1 Japan Neuromodulation Market Size (2014-2019)
• 8.2 Neuromodulation Key Players in Japan
• 8.3 Japan Neuromodulation Market Size by Type
• 8.4 Japan Neuromodulation Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Neuromodulation Market Size (2014-2019)
• 9.2 Neuromodulation Key Players in Southeast Asia
• 9.3 Southeast Asia Neuromodulation Market Size by Type
• 9.4 Southeast Asia Neuromodulation Market Size by Application

10 India

• 10.1 India Neuromodulation Market Size (2014-2019)
• 10.2 Neuromodulation Key Players in India
• 10.3 India Neuromodulation Market Size by Type
• 10.4 India Neuromodulation Market Size by Application

11 Central & South America

• 11.1 Central & South America Neuromodulation Market Size (2014-2019)
• 11.2 Neuromodulation Key Players in Central & South America
• 11.3 Central & South America Neuromodulation Market Size by Type
• 11.4 Central & South America Neuromodulation Market Size by Application

12 International Players Profiles

• 12.1 Medtronic
  • 12.1.1 Medtronic Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Neuromodulation Introduction
  • 12.1.4 Medtronic Revenue in Neuromodulation Business (2014-2019)
  • 12.1.5 Medtronic Recent Development
• 12.2 Boston Scientific
  • 12.2.1 Boston Scientific Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Neuromodulation Introduction
  • 12.2.4 Boston Scientific Revenue in Neuromodulation Business (2014-2019)
  • 12.2.5 Boston Scientific Recent Development
• 12.3 Jude Medical
  • 12.3.1 Jude Medical Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Neuromodulation Introduction
  • 12.3.4 Jude Medical Revenue in Neuromodulation Business (2014-2019)
  • 12.3.5 Jude Medical Recent Development
• 12.4 Synapse Biomedical
  • 12.4.1 Synapse Biomedical Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Neuromodulation Introduction
  • 12.4.4 Synapse Biomedical Revenue in Neuromodulation Business (2014-2019)
  • 12.4.5 Synapse Biomedical Recent Development
• 12.5 Nevro
  • 12.5.1 Nevro Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Neuromodulation Introduction
  • 12.5.4 Nevro Revenue in Neuromodulation Business (2014-2019)
  • 12.5.5 Nevro Recent Development
• 12.6 Neurosigma
  • 12.6.1 Neurosigma Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Neuromodulation Introduction
  • 12.6.4 Neurosigma Revenue in Neuromodulation Business (2014-2019)
  • 12.6.5 Neurosigma Recent Development
• 12.7 Neuropace
  • 12.7.1 Neuropace Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Neuromodulation Introduction
  • 12.7.4 Neuropace Revenue in Neuromodulation Business (2014-2019)
  • 12.7.5 Neuropace Recent Development
• 12.8 Neuronetics
  • 12.8.1 Neuronetics Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Neuromodulation Introduction
  • 12.8.4 Neuronetics Revenue in Neuromodulation Business (2014-2019)
  • 12.8.5 Neuronetics Recent Development
• 12.9 Cyber​​onics
  • 12.9.1 Cyber​​onics Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Neuromodulation Introduction
  • 12.9.4 Cyber​​onics Revenue in Neuromodulation Business (2014-2019)
  • 12.9.5 Cyber​​onics Recent Development
• 12.10 BioControl Medical
  • 12.10.1 BioControl Medical Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Neuromodulation Introduction
  • 12.10.4 BioControl Medical Revenue in Neuromodulation Business (2014-2019)
  • 12.10.5 BioControl Medical Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.
The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market.
Spinal cord stimulation is the dominating segment whereas repetitive transcranial magnetic stimulation is the fastest growing segment among various neuromodulation technologies. Chronic pain management is the largest application segment and migraine is the fastest growing segment owing to the high incidence rate.
North America is the most attractive market in the global neuromodulation industry and is expected to be the first preference for new entrants due to the increasing end-use in the region. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.
In 2018, the global Neuromodulation market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Neuromodulation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuromodulation development in United States, Europe and China.

The key players covered in this study
Medtronic
Boston Scientific
Jude Medical
Synapse Biomedical
Nevro
Neurosigma
Neuropace
Neuronetics
Cyber​​onics
BioControl Medical

Market segment by Type, the product can be split into
Deep Brain Stimulation
Spinal Cord Stimulation
Transcranial Magnetic Stimulation

Market segment by Application, split into
Depression
Parkinson’s
Tinnitus
Alzheimer’s
Epilepsy
Ischemia
Obesity

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Neuromodulation status, future forecast, growth opportunity, key market and key players.
To present the Neuromodulation development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Neuromodulation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.